AMI Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

AMI Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,135	Closed	-$1.15M	–	106
2026 Q2	$1.15M	Sell	2,135 -478	-18%	-$245K	0.07%	48
2026 Q1	$1.37M	Sell	2,613 -139	-5%	-$66.4K	0.09%	39
2025 Q4	$1.6M	Sell	2,752 -674	-20%	-$344K	0.09%	43
2025 Q3	$1.57M	Sell	3,426 -14	-0.4%	-$5.22K	0.09%	44
2025 Q2	$1.04M	Sell	3,440 -2,060	-37%	-$614K	0.06%	49
2025 Q1	$1.82M	Buy	5,500 +522	+10%	+$172K	0.11%	48
2024 Q4	$1.54M	Sell	4,978 -35	-0.7%	-$9.8K	0.08%	51
2024 Q3	$1.06M	Sell	5,013 -472	-9%	-$121K	0.06%	66
2024 Q2	$1.54M	Sell	5,485 -4,133	-43%	-$984K	0.08%	51
2024 Q1	$2.57M	Buy	9,618 +4,845	+102%	+$1.14M	0.13%	62
2023 Q4	$1.1M	Buy	+4,773	New	+$835K	0.06%	69

Other funds holding MDGL

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return

SAM

Shikiar Asset Management New York $398M AUM 33.64% 1-Year Est. Return

Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

AMI Asset Management's MDGL Position: Q3 2026 in Review

AMI Asset Management sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2026, closing a stake of 2,135 shares — an estimated $1.15M sold.

AMI Asset Management first reported a position in MDGL in Q4 2023 and held it in 11 quarters. The position peaked at $2.57M in Q1 2024. 46 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

AMI Asset Management reported no remaining Madrigal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
AMI Asset Management sold 2,135 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $1.15M.
AMI Asset Management first reported a position in Madrigal Pharmaceuticals in Q4 2023 and held it in 11 quarters.
AMI Asset Management's Madrigal Pharmaceuticals position peaked at $2.57M in Q1 2024.
46 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on AMI Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.